FindTrial
Sign In

to study ovarian cancers and hormone receptor expression on them

â??Histopathological spectrum of ovarian tumors with emphasis on estrogen and progesterone receptor expression and their correlation with clinicopathological parameters

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047202
Enrollment
70
Registered
2022-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Control Intervention1: Nil: Nil

Sponsors

Rohilkhand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the cases of ovarian tumors received in department of pathology and diagnosed on histopathology in Rohilkhand medical college and hospital during the study period.

Exclusion criteria

Exclusion criteria: Non neoplastic lesions as diagnosed by histopathology

Design outcomes

Primary

MeasureTime frame
To study histopathological spectrum of ovarian tumors with emphasis on estrogen & progesterone receptor expression and their correlation with clinicopathological parameters.Timepoint: After operative procedure—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Anjana Arya

Rohilkhand Medical College and Hospital

rstyagi94@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026